Publish Time: 2026-07-20 Origin: Site
Content Menu
● How Experienced Buyers Evaluate Polynucleotide Suppliers
>> 1. Factory Certification and Regulatory Readiness
>> 2. R&D Capability and Technical Service
>> 3. QC Process, Traceability and Documentation
>> 4. Capacity, MOQ and Delivery Stability
>> 5. OEM/ODM Flexibility and Communication Efficiency
● Top 10 Polynucleotide Manufacturers in China
>> Bloomage Biotechnology Corporation Limited
>> Hebei Jiheng (or similar biotech/chemical group in Hebei)
>> Xi'an Tian Guangyuan Biotech Co., Ltd.
>> Wuhan-based Peptide and Nucleotide Manufacturers
>> Shanghai GL Biochem and Similar Peptide/Nucleotide Specialists
>> Xi'an Quanao Biotech Co., Ltd. (Representative Natural & Functional Active Supplier)
>> Guangdong and Shenzhen Cosmetic Raw Material Integrators
>> Hangzhou- and Ningbo-based Biotech Firms
>> Other Emerging Polynucleotide and Bioactive Specialists
● Comparison Overview of Representative Manufacturers
● Common Pitfalls When Sourcing Polynucleotides from China
>> Pitfall 1: Confusing Technical Grade with Cosmetic Grade
>> Pitfall 2: Over-Reliance on Scanned Certificates
>> Pitfall 3: Inconsistent Batch Quality Hidden by Selective COA Sharing
>> Pitfall 4: Misalignment Between Sales Promises and Plant Reality
>> Pitfall 5: Underestimating Packaging and Logistics Details
● Internal "Insider" Tip: The Pilot Batch Trap
● Buyer's Guide: Due Diligence and Cooperation Flow
>> Step 1: Shortlisting and Initial Screening
>> Step 2: Verification of Certificates and Compliance
>> Step 3: Technical and QC Evaluation
>> Step 4: Pilot Samples and Lab Evaluation
>> Step 5: On-Site or Third-Party Audits
>> Step 6: Scaling Up with Structured Contracts
● Frequently Asked Questions from Professional Buyers
China has rapidly developed into a key production base for cosmetic-grade polynucleotide and related bioactive ingredients, supported by mature biotechnology clusters and a highly competitive cosmetic raw material supply chain. For international brand owners, distributors and OEM/ODM manufacturers, choosing the right Chinese partner can significantly improve cost-to-performance ratios, formulation flexibility and speed to market—provided that plant qualification and risk control are handled with professional rigor.
This guide is written from the perspective of international procurement managers and technical buyers who are seeking long-term partners rather than one-off transactions. It explains how experienced buyers evaluate factories, then presents ten representative manufacturers, including both large-scale groups and more flexible, R&D-driven plants that serve emerging brands.
Seasoned buyers do not start with price; they start with risk and reliability. The following dimensions are commonly used when screening and ranking polynucleotide manufacturers in China.
For cosmetic-grade polynucleotide and related actives, professional buyers usually pay attention to:
- Valid ISO 9001 or equivalent quality management systems.
- Cosmetic or food safety systems (such as ISO 22716 for cosmetics, or HACCP-type systems when relevant).
- Registration or filing experience in target markets (EU, UK, US, Southeast Asia, Middle East).
- Existence of internal regulatory teams that can support dossiers, safety assessments and technical files.
Rather than accepting scanned certificates at face value, mature buyers will independently verify certificate numbers on issuing bodies' official databases and check the expiration date and scope. This is especially important when polynucleotides are used in borderline products close to medical devices or injectable aesthetics.
Because polynucleotides are often combined with peptides, hyaluronic acid, niacinamide and other actives, factories with deeper formulation and process know‑how are more valuable in the long run. Indicators of strong R&D capability include:
- Dedicated in‑house laboratories with analytical equipment for molecular weight distribution, purity and microbiology.
- Scientists or engineers with backgrounds in biotechnology, fermentation, chemistry or pharmaceutical sciences.
- Ability to support customized molecular weight ranges, specific solvents, and formulation compatibility testing.
- Willingness to co-develop exclusive specifications and provide data packages for efficacy and safety.
In practice, buyers often test this by sending a challenging formulation brief and evaluating how quickly and precisely the technical team responds.
For polynucleotides used close to the skin barrier, strong quality control is non‑negotiable. Key aspects include:
- Batch‑level traceability from raw material to finished product.
- Clear specifications and certificates of analysis (COA) that cover appearance, content, purity, heavy metals, residual solvents, endotoxins (where relevant) and microbiology.
- Routine use of third‑party accredited labs for cross‑checking critical parameters.
- Stability study data under different temperature and humidity conditions.
Experienced buyers often request anonymized historical COA sets for at least 3–5 past batches to assess batch consistency before placing larger orders.
Capacity is not just about maximum tonnage. For polynucleotides, the practical questions are:
- What is the typical batch size, and how many batches per month can be allocated to export clients?
- What is the minimum order quantity (MOQ) for standard and customized grades?
- How long is the standard lead time for repeat orders, and what are the realistic shortest and longest scenarios?
- How does the plant handle raw material shortages or emergency orders?
Buyers focusing on clinical‑style aesthetics products typically prefer plants that can handle frequent but smaller production cycles with strict consistency, not only high-volume runs.
Because many polynucleotide projects involve private-label products, international buyers care strongly about:
- Support for small and medium-sized MOQs for new launches.
- Custom packaging (vials, sachets, ampoules), labeling, and documentation in multiple languages.
- Responsiveness of English communication and presence of a dedicated project manager.
- Ability to handle cross-border logistics arrangements, including cold-chain if needed, and to prepare documentation for customs and local authorities.
Factories that maintain honest communication about risks and limitations—even if it means giving answers that buyers do not want to hear—are usually more trustworthy partners.
The following companies are representative of the current Chinese landscape in cosmetic and biotech ingredients related to polynucleotides. Information is compiled from public company materials, industry exchanges and export experience. Buyers should always conduct their own due diligence and on-site verification before awarding large-volume or high-risk projects.
ZHENYIBIO TECHNOLOGY INC is a high-tech manufacturer focusing on natural plant-based active cosmetic ingredients, combining traditional botanical knowledge with modern biotechnology and fermentation processes. The company positions itself as a partner for global beauty brands that require both scientific support and a sustainable sourcing concept, and it serves foreign brand owners, wholesalers and manufacturers with OEM and ODM services.
Unlike large conglomerates that primarily target multinational corporations, ZHENYIBIO is particularly suitable for small to medium-sized and emerging brands that need higher flexibility. The company emphasizes:
- Strong R&D capability in plant-based and bioactive cosmetic ingredients, with an internal technical team that supports custom formulation requirements.
- Rigorous quality management and practical documentation to match export market needs, while keeping communication channels efficient and transparent.
- Willingness to support lower MOQs for customized products, diverse packaging needs, and iterative formulation adjustments as brands refine their positioning.
Because of this flexibility and responsiveness, ZHENYIBIO often fits buyers who value close collaboration, technical dialogue and co-development of differentiated products, rather than purely transactional bulk purchasing.
Bloomage Biotechnology, headquartered in Shandong, is widely known for its hyaluronic acid production and has gradually expanded into a broader portfolio of bioactive cosmetic ingredients, including nucleotides and biotechnology-derived actives. Established in the late 1990s, it serves both domestic and international top-tier cosmetics groups. The company operates multiple GMP-standard facilities and focuses on high-purity, fermentation-based ingredients with extensive safety and efficacy data.
Bloomage typically targets mid-to-large brands and contract manufacturers with relatively higher MOQs but offers strong documentation support and a comprehensive regulatory background. Its main strengths lie in large-scale capacity, robust quality systems and the ability to provide integrated portfolios rather than single-ingredient sourcing.
Hebei has a concentration of chemical and biotech suppliers that serve both pharmaceutical intermediates and cosmetic raw materials. Within this environment, Jiheng-type groups operate large chemical and biochemical plants that can offer nucleotides and related raw materials as part of a broader portfolio. These companies are attractive for buyers needing a combination of traditional chemical components and more advanced actives.
Their advantages usually include competitive pricing, strong export experience for hundreds of SKU categories, and well-established documentation processes. However, buyers should pay particular attention to confirming cosmetic-grade specifications, as some lines may still be primarily designed for industrial or technical grades.
Xi'an is one of China's most mature hubs for plant extracts and natural actives, and Xi'an Tian Guangyuan Biotech is representative of suppliers that have moved up the value chain into more specialized cosmetic ingredients. The company offers a wide range of botanical extracts and functional components, and may also carry polynucleotide-related materials and synergistic actives for anti-aging and skin-repair formulations.
Its core advantage lies in breadth of natural ingredients, flexible packaging, and experience working with overseas distributors. For buyers seeking to combine polynucleotides with plant extracts or build clean-beauty positioning, such a supplier can offer integrated sourcing and basic formulation recommendations.
Wuhan has developed a strong cluster of peptide and biochemical manufacturers that provide raw materials to pharmaceutical, cosmetic and research sectors. Companies in this cluster often specialize in custom peptide synthesis, nucleotides and related compounds. Their main strengths are process customization, small-to-medium batch production and analytical capability.
Buyers who need polynucleotides in specialized forms or combined peptide–nucleotide systems for advanced skin-repair products often find Wuhan-based suppliers suitable for pilot projects and early-stage launches. At the same time, capacity and MOQs may vary significantly between companies, so careful plant audits and pilot orders are recommended.
Shanghai hosts several well-known peptide and nucleotide manufacturers, such as GL Biochem-type companies, that have decades of experience with peptide synthesis, nucleotides and biochemical reagents. These firms traditionally served the pharmaceutical and research markets but increasingly support cosmetic applications via cosmetic-grade and personal-care-grade specifications.
Advantages include strong technical background, well-equipped laboratories and the ability to implement strict analytical testing for purity and residuals. These manufacturers generally suit buyers who are more familiar with pharmaceutical standards and who demand detailed analytical documentation. The trade-off is that pricing can be higher and minimum order quantities for custom work are not always low.
Xi'an Quanao and similar companies represent a group of suppliers that integrate traditional Chinese herbal extracts with modern cosmetic actives and functional ingredients. While their historical strength lies in botanicals, they increasingly add functional molecules and bioactive complexes to support anti-aging, brightening and repair lines.
Their typical advantages are strong familiarity with natural ingredients, flexible small-batch production, and the ability to align with "green" and "clean" marketing narratives. Buyers targeting niche natural or indie brands can leverage such suppliers to build polynucleotide-containing formulas that are still strongly positioned as nature-inspired.
The Pearl River Delta, including Guangzhou and Shenzhen, hosts numerous integrators that build full ingredient portfolios for OEM/ODM cosmetic factories. Some of these companies act as traders and partial manufacturers for polynucleotides, peptides, hyaluronic acid and a wide range of surfactants and functional additives.
The key strength of these integrators is their deep connection to the finished-product factories in South China, which allows them to rapidly match ingredients, packaging and full-service OEM projects. For buyers who want one partner to coordinate ingredients and finished-product manufacturing, such integrators are often a practical option. However, it is essential to distinguish between pure traders and those with real manufacturing assets and labs.
In the Yangtze River Delta, Hangzhou and Ningbo host a growing number of biotechnology firms that offer enzymes, nucleotides, peptides and fermentation-derived cosmetic actives. These firms tend to be relatively young but are founded by teams with academic and industrial biotech backgrounds.
Their advantages include a strong innovation mindset, openness to joint development, and willingness to adjust processes for special grade requirements. They often provide competitive solutions for brands aiming to differentiate through science-backed claims and innovative textures. Buyers should engage in deeper technical discussions to ensure alignment on specifications, test methods and stability.
Beyond the well-known names, there is a growing group of emerging Chinese companies dedicated to bioactive ingredients, including polynucleotides and nucleic acid-derived actives for skin repair and anti-aging. These firms are often spin-offs from research institutes or pharmaceutical entities and focus on:
- Highly specialized processes and narrow product lines.
- Advanced delivery systems, such as liposomes or nano-emulsions, combining polynucleotides with other actives.
- Customized project-based cooperation with selected overseas partners.
For experienced procurement managers, these emerging specialists can provide strong differentiation and technical depth, but they require more intensive due diligence, on-site audits and stepwise project scaling.
The table below provides a simplified comparison of some key dimensions that buyers typically analyze. Values are generalized to illustrate typical positioning; actual figures differ by company and specific product line.
| Manufacturer Type | Typical Capacity Level | MOQ Range (Cosmetic Grade) | Main Strengths | Typical Client Profile |
|---|---|---|---|---|
| ZHENYIBIO TECHNOLOGY INC | Medium | Low to medium | Flexible OEM/ODM for SMEs, plant-based expertise | Small/medium brands, niche and emerging labels |
| Large biotech group (e.g., Bloomage-type) | High | Medium to high | Strong QC, documentation, multi-site facilities | Large brands, major OEMs |
| Hebei chemical/biotech group | High | Medium | Broad portfolio, competitive pricing | Traders, contract manufacturers |
| Xi'an botanical & actives supplier | Medium | Low to medium | Natural actives, flexible packaging | Indie brands, natural-focused OEMs |
| Wuhan peptide/nucleotide specialist | Medium | Low to medium | Custom processes, analytical depth | Clinical-style aesthetic brands, R&D projects |
| Shanghai peptide/biochemical firm | Medium to high | Medium to high | Strong analytical labs, pharma-style standards | Technically demanding buyers |
| Guangdong/Shenzhen integrator | Medium | Low to medium | Full portfolios, OEM connections | Buyers needing integrated ingredient & OEM |
| Hangzhou/Ningbo biotech firm | Medium | Low to medium | Innovation, process customization | Brands seeking novel bioactives |
| Emerging nucleic acid specialists | Low to medium | Project-based | Niche technology, high differentiation | Strategic partners, long-term innovation plans |
Professional buyers know that the main risks seldom come from obvious issues like missing labels; they come from structural and hidden mismatches between claims and actual capabilities.
Some suppliers originally serving pharmaceutical intermediates or research labs may list polynucleotides with impressive purity figures, but the grade or impurity profile can be unsuitable for cosmetic use. The specifications may not adequately define microbiological limits, heavy metals or allergen-related parameters. Buyers should insist on cosmetic- or personal-care-grade specifications and check how those specifications are monitored batch to batch.
A common internal rule among experienced buyers is: "never trust a certificate screenshot alone." Certificates can be outdated, limited in scope, or issued for a different production site. Always verify certificate numbers on official directories, cross-check addresses, and require a clearly stamped list of manufacturing sites covered by each certificate.
Some factories only share the "best" batch COA when pitching overseas clients. An internal practice among mature buyers is to request multiple historical COAs spanning several months or seasons, then analyze the variation of key parameters. Large fluctuations in purity, moisture or microbiology are a warning signal, even when each batch individually appears to pass.
In certain cases, what is presented in catalogs and sales decks does not match the actual production capabilities of the facility. An important internal guideline is to have technical staff or a third-party inspector interview the plant's production and QC teams directly, and to review batch records or production logs, rather than relying solely on commercial staff.
For polynucleotides, packaging (including protection from light, moisture and temperature swings) and shipping conditions are critical. Even a technically strong supplier can cause serious quality problems if packaging is not designed for long-distance transport or if the shipping mode does not fit the sensitivity level of the material.
One insider guideline often discussed among experienced buyers—but rarely written online—is to pay special attention to the second and third batches, not only the first trial order. Many factories will allocate extra attention and resources to the initial pilot batch for a new overseas client, making sure everything looks perfect. Problems sometimes appear when the project moves into what they perceive as routine production.
A practical way to manage this is:
- Keep the second and third orders at controlled sizes while monitoring the stability of quality and lead times.
- Compare all COAs, and, where possible, send samples from each batch to the same independent lab for key parameter checks.
- Tie long-term volume commitments or price negotiations to performance across multiple consecutive batches rather than just the first delivery.
This approach helps buyers filter out suppliers who can only perform under "showcase" conditions and identify those who can consistently deliver production-level reliability.
For procurement managers who are new to polynucleotide sourcing in China, the following structured process is commonly used by experienced buyers.
- Define target specifications (grade, purity range, solvent system, microbiology limits) and intended markets.
- Build an initial supplier list based on manufacturing capability, not only trading websites.
- Ask each candidate for current certificates, a typical COA for the target product, and brief plant information.
- Independently verify ISO and other certificates on official bodies' websites.
- Confirm that the certificates cover the actual production site and product scope.
- Check whether the supplier already serves clients in similar markets or with similar regulatory requirements.
- Request detailed specifications and multiple historical COAs, asking specifically for those used in export projects.
- Clarify testing methods, detection limits and any special analytical techniques used.
- Discuss the supplier's approach to deviations and non-conformities and how they document corrective actions.
- Order lab-scale and small pilot batches, not only free samples.
- Conduct internal or third-party testing for critical parameters and, if possible, run small formulation trials.
- Evaluate the technical team's responsiveness when questions or issues arise.
- Arrange an on-site audit or appoint a trusted third party to review production, QC labs, documentation, hygiene and storage.
- Validate whether the actual plant layout and equipment match the technical descriptions and capacity claims.
- Observe how the plant manages raw material reception, in-process controls and finished-goods release.
- Start with moderate volumes and clearly defined specifications, acceptance criteria and rework/claim procedures.
- Gradually expand volumes and SKUs only after multiple successful batches and stable lead times.
- Maintain regular communication with both sales and technical teams, including periodic review meetings.
China's polynucleotide and related bioactive ingredient sector is supported by strong industrial clusters, a large domestic cosmetics market and a growing base of export-oriented factories. For international procurement managers, the main challenge is not the lack of options, but the need to differentiate between marketing claims and real, sustainable capabilities.
By systematically evaluating certification, R&D depth, QC systems, capacity, lead time stability and OEM/ODM flexibility, buyers can identify partners that match their strategic needs. Established biotech groups, specialized peptide and nucleotide manufacturers, natural-focused suppliers, integrators in key cosmetic regions and flexible R&D-driven plants such as ZHENYIBIO TECHNOLOGY INC each have their own positioning and strengths.
A disciplined approach—verifying certificates, analyzing historical batch data, carefully managing pilot and early production batches, and maintaining close technical communication—helps reduce risk and build stable, long-term cooperation. With this mindset, sourcing polynucleotides from China can become a reliable and scalable pillar of global beauty and personal care projects.
1. How can I confirm whether a manufacturer's ISO certificates are still valid and cover the correct site?
Request the certificate number and issuing body, then check the official database or website of that body. Verify the legal entity name, address, scope of certification and expiry date. Ensure that the site listed on the certificate matches the actual production address on shipping documents.
2. What is a reasonable MOQ for cosmetic-grade polynucleotides when working with a Chinese manufacturer?
For standard grades, many manufacturers set MOQs from 1–25 kg, while more customized grades may start higher. For projects involving OEM finished products, MOQs can also be determined by packaging constraints and filling lines, not only raw material batch sizes.
3. How do I evaluate if a supplier's QC capability is sufficient for near-medical or clinical-style aesthetic products?
Review their QC equipment list, ask for example test reports from third-party labs, and confirm that they can test parameters such as endotoxins and precise residual profiles if required. During audits, check how they calibrate instruments and store reference standards.
4. What documentation should I request before registering a polynucleotide-containing cosmetic in overseas markets?
Commonly requested documents include detailed specifications, MSDS, COA, manufacturing flow chart, impurity and residual solvents statements, allergen statements, and, if available, safety assessment summaries and stability data. Each market may have specific additional requirements, such as ingredient lists in certain formats.
5. How can I reduce the risk of quality shifts when transferring from pilot batches to continuous production?
Implement a phased approach: keep at least the first three production batches under enhanced monitoring, compare all COAs for key parameters, and retain retains for cross-checking. Include clear clauses in supply agreements about change control, including notification obligations for process or raw material changes.
1. China Export Data – Make-up or Skin Care Preparation, General Administration of Customs (via CEIC). https://www.ceicdata.com/en/china/usd-export-by-major-commodity-value/export-makeup-or-skin-care-preparation
2. Frost & Sullivan – China Cosmetics Raw Materials Market Report 2025 (overview page, Chinese). https://www.frostchina.com/en/content/insight/detail/6853ccc9f5861d47abef4157
3. Cosmetics Export Statistics 2025 – China Customs-based summary. https://www.entercogroup.com/post/cosmetics-exports-in-the-first-half-of-2025-18-7-billion-rmb-indonesia-soars-by-94
4. Overview of China Cosmetics Market Size 2025. https://www.yicaiglobal.com/news/chinas-cosmetics-market-exceeds-usd159-billion-in-2025
5. General directory of Chinese polynucleotide and related manufacturers. https://www.made-in-china.com/manufacturers/polynucleotide.html
6. Example of Chinese cosmetic raw material export data and supplier overview. https://www.volza.com/p/cosmetic-raw-material/manufacturers/manufacturers-in-china/
7. Example guidance on verifying cosmetic factory ISO and GMP-type certifications. https://guangzhoucosmeticmanufacturer.com/how-to-verify-gmpc-and-iso-cosmetics-factories-in-china-a-complete-b2b-sourcing-guide/
8. ZHENYIBIO TECHNOLOGY INC – Corporate profile and capabilities (About Us). https://www.zhenyibio.com/aboutus.html